ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats

Virginia Luis Fuentes1, Jonathan Abbott2, Valérie Chetboul3

  • 1Department of Clinical Science and Services, Royal Veterinary College, Hatfield, United Kingdom.

Insights

This consensus statement provides a new classification and staging system for feline cardiomyopathies, guiding diagnosis and management for better feline cardiac care.

Area of Science:

  • Veterinary Cardiology
  • Feline Medicine
  • Myocardial Diseases

Background:

  • Cardiomyopathies are common myocardial disorders in cats with varied prognoses.
  • These conditions can lead to severe outcomes like heart failure, thromboembolism, or sudden death.
  • Accurate classification and staging are crucial for effective management.

Purpose of the Study:

  • To establish a standardized classification system for feline cardiomyopathies based on phenotype.
  • To introduce a staging system, including risk stratification for subclinical cases.
  • To provide evidence-based recommendations for diagnosis, staging, and management.

Main Methods:

  • Review and synthesis of available scientific literature on feline cardiomyopathies.
  • Development of a consensus-based classification system using cardiac structure and function.
  • Creation of a staging protocol incorporating risk assessment for subclinical disease.

Main Results:

  • A phenotype-based classification system for feline cardiomyopathies has been outlined.
  • A comprehensive staging system, including risk stratification for subclinical cases, is introduced.
  • Recommendations for diagnostic and therapeutic approaches at each stage are provided.

Conclusions:

  • The proposed classification and staging systems aim to standardize the approach to feline cardiomyopathies.
  • This framework will aid veterinarians in diagnosing, staging, and managing cats with heart disease.
  • Improved understanding and management are expected to enhance outcomes for affected cats.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
413
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
230
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
231
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
283
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
366
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
244